{
    "id": "341458ca-1786-8c07-e063-6394a90a70df",
    "indications": {
        "text": "enoxaparin sodium injection low molecular weight heparin ( lmwh ) indicated : prophylaxis deep vein thrombosis ( dvt ) abdominal surgery , hip replacement surgery , knee replacement surgery , medical patients severely restricted mobility acute illness ( 1.1 ) inpatient treatment acute dvt without pulmonary embolism ( 1.2 ) outpatient treatment acute dvt without pulmonary embolism ( 1.2 ) prophylaxis ischemic complications unstable angina non-q-wave myocardial infarction ( myocardial infarction ) ( 1.3 ) treatment acute st-segment elevation myocardial infarction ( stemi ) managed medically subsequent percutaneous coronary intervention ( pci ) ( 1.4 )",
        "doid_entities": [
            {
                "text": "thrombosis (DOID:0060903)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0060903"
            },
            {
                "text": "pulmonary embolism (DOID:9477)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9477"
            },
            {
                "text": "unstable angina (DOID:8805)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8805"
            },
            {
                "text": "myocardial infarction (DOID:5844)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5844"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "full prescribing information dosing information . ( 2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "enoxaparin sodium injection , usp clear , colorless pale yellow solution supplied follows : 100 mg per ml concentration * strength represents number milligrams enoxaparin sodium water injection . \u2020approximate anti-factor xa activity based reference w.h.o . first international low molecular weight heparin reference standard . \u00a7each enoxaparin sodium injection , usp multi-dose vial contains 15 mg benzyl alcohol per 1 ml preservative . ndc strength * anti-xa activity \u2020 label color package factor 68001-641-41 300 mg per 3 ml multi-dose vial \u00a7 30,000 iu red 1 vial per carton store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) . [ usp controlled room temperature . ] store original carton packaging ready . store multi-dose vials 28 days first . sterile , nonpyrogenic . container closure made natural rubber latex .",
    "adverseReactions": "enoxaparin sodium contraindicated patients : active major bleeding history immune-mediated heparin-induced thrombocytopenia ( hit ) within past 100 days presence circulating antibodies [ ( 5.4 ) ] known hypersensitivity enoxaparin sodium ( e.g . , pruritus , urticaria , anaphylactic/anaphylactoid ) [ ( 6.2 ) ] known hypersensitivity heparin pork products known hypersensitivity benzyl alcohol [ ( 5.8 ) ]",
    "ingredients": [
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17987"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "ENOXAPARIN SODIUM",
            "code": "8NZ41MIK1O",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01225"
        }
    ],
    "organization": "BluePoint Laboratories",
    "name": "Enoxaparin Sodium",
    "effectiveTime": "20250501",
    "indications_original": "Enoxaparin Sodium Injection is a low molecular weight heparin (LMWH) indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness ( 1.1 ) Inpatient treatment of acute DVT with or without pulmonary embolism ( 1.2 ) Outpatient treatment of acute DVT without pulmonary embolism ( 1.2 ) Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction (MI) ( 1.3 ) Treatment of acute ST-segment elevation myocardial infarction (STEMI) managed medically or with subsequent percutaneous coronary intervention (PCI) ( 1.4 )",
    "contraindications_original": "See full prescribing information for dosing and administration information. ( 2 )",
    "warningsAndPrecautions_original": "Enoxaparin Sodium Injection, USP is a clear, colorless to pale yellow solution and is supplied as follows:\n                  \n                     100 mg per mL Concentration\n                     \n                     \n                     \n                     \n                     \n                     \n                        \n                           * Strength represents the number of milligrams of enoxaparin sodium in Water for Injection.\n                        \n                        \n                           \n                              \u2020Approximate anti-Factor Xa activity based on reference to the W.H.O. First International Low Molecular Weight Heparin Reference Standard.\n   \n    \n                        \n                        \n                           \n                              \u00a7Each Enoxaparin Sodium Injection, USP multi-dose vial contains 15 mg benzyl alcohol per 1 mL as a preservative.\n   \n    \n                        \n                     \n                     \n                        \n                           \n                              \n                                 NDC\n                              \n                           \n                           \n                              \n                                 Strength*\n                              \n                           \n                           \n                              \n                                 Anti-Xa Activity\n      \n       \u2020\n                                 \n                              \n                           \n                           \n                              \n                                 Label Color\n                              \n                           \n                           \n                              \n                                 Package Factor\n                              \n                           \n                        \n                        \n                           \n                              68001-641-41\n                           \n                           \n                              300 mg per 3 mL Multi-Dose Vial\n     \n      \u00a7\n                              \n                           \n                           \n                              30,000 IU\n                           \n                           \n                              Red\n                           \n                           \n                              1 vial per carton\n                           \n                        \n                     \n                  \n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); excursions permitted between 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F). [See USP Controlled Room Temperature.] Store in the original carton or packaging until ready to use.\n                  Do not store the multi-dose vials for more than 28 days after the first use.\n                  \n                     Sterile, Nonpyrogenic.\n                  \n                  \n                     The container closure is not made with natural rubber latex.",
    "adverseReactions_original": "Enoxaparin sodium is contraindicated in patients with:\n                  \n                     Active major bleeding\n                     History of immune-mediated heparin-induced thrombocytopenia (HIT) within the past 100 days or in the presence of circulating antibodies\n  \n   [see Warnings and Precautions (\n   \n    5.4)]\n  \n   \n                     \n                     Known hypersensitivity to enoxaparin sodium (e.g., pruritus, urticaria, anaphylactic/anaphylactoid reactions)\n  \n   [see Adverse Reactions (\n   \n    6.2)]\n  \n   \n                     \n                     Known hypersensitivity to heparin or pork products\n                     Known hypersensitivity to benzyl alcohol\n  \n   [see Warnings and Precautions (\n   \n    5.8)]",
    "drug": [
        {
            "name": "Enoxaparin Sodium",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01225"
        }
    ]
}